Drug profile · INN
amantadine
AMANTAMED
amantadine (AMANTAMED) is a glutamate [nmda] receptor antagonist. Associated with Novartis Pharmaceuticals. Route of administration: oral. Current US regulatory status: approved.
Drug details — amantadine
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
amantadine (AMANTAMED) is a glutamate [nmda] receptor antagonist. Associated with Novartis Pharmaceuticals. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Glutamate [NMDA] receptor antagonist
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is amantadine?
amantadine (AMANTAMED) is a glutamate [nmda] receptor antagonist. Associated with Novartis Pharmaceuticals. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for amantadine?
AMANTAMED is a marketed brand name for amantadine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of amantadine?
amantadine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.